Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1905 - 1912 of 11616 results
Post-Dobbs Abortion-Related Travel Benefits: Surveying Employers’ Options
July 13, 2022| Blog| Viewpoint
FDA’s Review of Pulse Oximeter Performance Continues a Trend in Addressing Biases in Digital Health Technologies
July 12, 2022| Blog| Viewpoint
Stress-Testing A Real Estate JV Ahead Of New Challenges
July 12, 2022| News
Real Estate Joint Ventures: Stress-Testing New Challenges
July 12, 2022| News
Some Employee Chatter About Abortion Decision May Be Protected
July 12, 2022| News
Health Insurance Maintenance During Massachusetts Paid Family and Medical Leave - Draft Regulations Issued
July 11, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.